| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | +12.5% |
| Cost of Revenue | $931K | +10.3% |
| Gross Profit | $4.3M | +13.0% |
| R&D Expense | $100K | -39.0% |
| SG&A Expense | $9.7M | +6.1% |
| Operating Income | -$5.4M | -1.3% |
| Interest Expense | $98K | +6.5% |
| Net Income | -$5.5M | -17.3% |
| EPS (Basic) | -$0.86 |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $35K | -82.0% |
| Inventory | $423K | +82.3% |
| Current Assets | $958K | -17.8% |
| Total Assets | $1.5M | -7.1% |
| Current Liabilities | $2.9M | -12.6% |
| Total Liabilities | $3.0M | -10.5% |
| Stockholders' Equity | -$1.4M | +13.9% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$718K | +50.5% |
| Capital Expenditures | $23K | — |
| Investing Cash Flow | -$23K | +48.9% |
| Financing Cash Flow | $305K | -23.0% |
| Free Cash Flow | -$741K | — |
| -16.2% |
| EPS (Diluted) | -$0.86 | -16.2% |